Study title: Report on Protocol AI414-128, A Non-Comparative Trial of Cefprozil in the Treatment of Acute Hematogenous Osteomyelitis and/or Suppurative Arthritis in Pediatric Subjects.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Otorhinolaryngologic Diseases [C09] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CEFPROZIL | |||||
ATC code: | |||||
Document link: Protocol ai414-128 Cefprozil.pdf | |||||
Document date: 2011-09-21 | |||||
Study number: AI414-128 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |